WFC Options Caution Rises as Stock Slips from Recovery High

Wells Fargo pulled back 1.5% on Wednesday to $86.42. Options traders are the most defensive they've been in two weeks.

The put/call ratio hit 1.38 on July 22. That's 2.2 standard deviations above its 20-day mean of 1.28. The ratio has climbed steadily since mid-July, when it sat near 1.22. It remains well below the 52-week high of 1.58, but the directional move is notable given the stock had only recently recovered from its post-earnings dip.

Options Traders Flag the Pullback

The PCR trend tells a clean story. WFC spent most of June above 1.38 — a period that coincided with pre-earnings caution. It then compressed through mid-July as the stock recovered. Now it's climbing again. That two-week low in PCR around July 14–16 was the calm after the earnings storm. The current re-expansion suggests some traders are hedging the recovery.

The stock is off 1.2% on the week. Peers are mixed: BAC gained 1.3% on the day while KEY fell 1.6%. WFC's move isn't dramatically out of step with the sector, but it's underperforming the large-cap end of the peer group.

Lending Market Stays Quiet

The borrow story has unwound almost entirely. Cost to borrow is now 0.24%, down 75% from the brief spike above 0.93% seen around the July 14 earnings date. Availability is essentially unlimited — the lending pool is showing no strain. Short interest sits at 0.91% of the free float. That's a low level and telling no directional story on its own.

The brief CTB spike was a noise event, not the start of a squeeze. It has fully normalized.

The Bigger Picture

The mean analyst price target is $99.80 — roughly 15% above current levels. That gap has persisted since the post-earnings recalibration. BofA holds a $102 Buy. UBS sits at $104 Buy. Both were set before results and remain intact. Keefe, Bruyette & Woods trimmed to $94 from $98, and Baird raised to $92 from $85, keeping Neutral. The dispersion of targets reflects a stock where the bull and bear cases are genuinely contested.

Next earnings: October 13.

Data Summary

• Price: $86.42, –1.5% on the day, –1.2% on the week
• PCR: 1.38, z-score +2.2 vs. 20-day mean of 1.28
• SI % of FF: 0.91% — low, no directional read
• Cost to borrow: 0.24%, down 75% week-over-week
• Availability: Essentially unlimited
• Consensus target: $99.80 (~+15% implied upside)
• Next earnings: October 13, 2026